6 Meridian’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$380K Buy
7,575
+91
+1% +$4.71K 0.03% 198
2021
Q3
$397K Buy
+7,484
New +$422K 0.03% 194
2019
Q3
Sell
-20,811
Closed -$582K 485
2019
Q2
$582K Buy
20,811
+322
+2% +$8.95K 0.06% 200
2019
Q1
$635K Buy
+20,489
New +$547K 0.06% 169

Other funds holding LMAT

6 Meridian's LMAT Position: Q4 2021 in Review

6 Meridian increased its LeMaitre Vascular (LMAT) stake by 1.2% in Q4 2021, buying an estimated $4.71K and bringing the position to 7,575 shares worth $380K. The position accounts for 0.03% of the portfolio, ranked #198.

6 Meridian first reported a position in LMAT in Q1 2019 and has held it in 4 quarters since. The position peaked at $635K in Q1 2019. 183 funds tracked by Wall St. Rank hold LMAT as of Q4 2021.

  • 6 Meridian held 7,575 shares of LeMaitre Vascular worth $380K as of Q4 2021.
  • 6 Meridian bought 91 LeMaitre Vascular shares in Q4 2021, an estimated $4.71K.
  • LeMaitre Vascular made up 0.03% of 6 Meridian's portfolio in Q4 2021, its #198 holding.
  • 6 Meridian first reported a position in LeMaitre Vascular in Q1 2019 and has held it in 4 quarters since.
  • 6 Meridian's LeMaitre Vascular position peaked at $635K in Q1 2019.
  • 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2021.

Based on 6 Meridian's 13F filing for Q4 2021, filed 1 Feb 2022.